MyoMatrix™ / MyoSponge™
Volumetric Muscle Loss (from trauma, surgery, disease)
Pre-clinicalActive
Key Facts
Indication
Volumetric Muscle Loss (from trauma, surgery, disease)
Phase
Pre-clinical
Status
Active
Company
About GenAssist
GenAssist is a preclinical-stage biotech company pioneering a novel regenerative therapy for severe muscle trauma. Its core technology, MyoMatrix™, is a biomimetic, off-the-shelf scaffold that provides structural support and biological cues to guide the body's own cells to rebuild functional muscle, as demonstrated in animal studies showing significant strength recovery. The company is targeting a significant unmet medical need in military, trauma, and surgical care, supported by non-dilutive SBIR funding and a lean, experienced founding team. GenAssist's approach aims to prevent long-term disability from untreated muscle injuries.
View full company profile